CS1 (or SLAMF7 [a CD2-like receptor-activating cytotoxic cells], CRACC, or CD319) is a type I membrane glycoprotein; it is highly expressed on malignant plasma cells, but its function on MM cells remains unclear [109]. Here, SLAMF7 is linked to Miyoshi myopathy.